Notably, siRNA against HIF-1α can reduce the ability of murine glioma cells to migrate [114] accompanied by decreased immunophenotype levels of HIF-1α transcriptional targets, including among others VEGF, and CA-IX [118]. The gene discussed is HIF1A; the disease is central nervous system cancer.